Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis

A. Martini, A. Ravelli, G. Di Fuccia, V. Rosti, M. Cazzola, G. Barosi

Research output: Contribution to journalArticle


The role of iron supplementation in treating the anaemia of systemic-onset juvenile chronic arthritis is not clear. Eight affected children with severe persistent anaemia unresponsive to oral iron therapy were treated with intravenous iron saccharate. From a median post-oral-iron value of 8·0 g/dL (range 6·5-9·5), haemoglobin rose to 11·0 g/dL (10·1-12·1) (p=0·01). The concentration of serum transferrin receptor, an indicator of iron deficiency, before intravenous therapy correlated with the increase in haemoglobin (r=0·88, p

Original languageEnglish
Pages (from-to)1052-1054
Number of pages3
Issue number8929
Publication statusPublished - Oct 15 1994


ASJC Scopus subject areas

  • Medicine(all)

Cite this